Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya.
about
Magnitude and Predictors of Anti-Retroviral Treatment (ART) Failure in Private Health Facilities in Addis Ababa, EthiopiaImmunological failure of first-line and switch to second-line antiretroviral therapy among HIV-infected persons in Tanzania: analysis of routinely collected national data.Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring.Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on antiretroviral therapy.Characterization of treatment failure in HIV positive patients in the Colombian Caribbean region.Lack of awareness of treatment failure among HIV-1-infected patients in Guinea-Bissau - a retrospective cohort studyOptions to Expand HIV Viral Load Testing in South Africa: Evaluation of the GeneXpert® HIV-1 Viral Load Assay.Assessment of the magnitude and associated factors of immunological failure among adult and adolescent HIV-infected patients in St. Luke and Tulubolo Hospital, Oromia Region, EthiopiaEffect of a clinical decision support system on early action on immunological treatment failure in patients with HIV in Kenya: a cluster randomised controlled trial.Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapyPredictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia.Sensitivity and specificity of two dried blood spot methods for HIV-1 viral load monitoring among patients in Hanoi, Vietnam.
P2860
Q28547030-FBB7A1FF-F0A2-46D3-B2CF-3ED2BC66208DQ30911364-EF1D769B-0A9D-4DFF-9022-ECF287B90899Q30944694-D350232E-5BF2-4BEC-99D1-6640C78074ACQ33764793-A491E248-3EFB-4439-9826-AD09C1376851Q34195328-802A896F-8AE0-45ED-878F-C24FBF0B7313Q35149749-8D314CA8-A397-46BA-A663-BE67A3BD3983Q36110959-ED3B69F9-FA14-4FEE-99B8-7B607C0BBF71Q36228238-C3A9804E-5316-4D19-A027-0D6523A245B6Q36250979-2E87A087-3424-4414-8408-74A52C43765CQ36649577-17986B5A-DCDE-4A38-94AE-B6F13A3CBB5CQ37225313-101736C3-AF7F-4FD4-B86B-B802EABF90ABQ47115571-33670BA5-BA8A-4AA2-9F08-01E39DC83FDBQ47551829-DDB8016E-918F-4932-929B-D23F185DE677
P2860
Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Evaluation of clinical and imm ...... atment cohort in Busia, Kenya.
@ast
Evaluation of clinical and imm ...... atment cohort in Busia, Kenya.
@en
Evaluation of clinical and imm ...... atment cohort in Busia, Kenya.
@nl
type
label
Evaluation of clinical and imm ...... atment cohort in Busia, Kenya.
@ast
Evaluation of clinical and imm ...... atment cohort in Busia, Kenya.
@en
Evaluation of clinical and imm ...... atment cohort in Busia, Kenya.
@nl
prefLabel
Evaluation of clinical and imm ...... atment cohort in Busia, Kenya.
@ast
Evaluation of clinical and imm ...... atment cohort in Busia, Kenya.
@en
Evaluation of clinical and imm ...... atment cohort in Busia, Kenya.
@nl
P2093
P2860
P1433
P1476
Evaluation of clinical and imm ...... atment cohort in Busia, Kenya.
@en
P2093
Ana Alvarez
Andrea Bernasconi
Ashimosi S Khamadi
Cecilia Ferreyra
David Dalmau
Elena Alonso
Elena Velilla
Laurence Flevaud
Martha Kihara Mugendi
Matilu Mwau
P2860
P304
P356
10.1371/JOURNAL.PONE.0049834
P407
P577
2012-11-21T00:00:00Z